TY - JOUR
T1 - Counter-regulatory renin–angiotensin system in cardiovascular disease
AU - Paz Ocaranza, Maria
AU - Riquelme, Jaime A.
AU - García, Lorena
AU - Jalil, Jorge E.
AU - Chiong, Mario
AU - Santos, Robson A.S.
AU - Lavandero, Sergio
N1 - Publisher Copyright:
© 2019, Springer Nature Limited.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - The renin–angiotensin system is an important component of the cardiovascular system. Mounting evidence suggests that the metabolic products of angiotensin I and II — initially thought to be biologically inactive — have key roles in cardiovascular physiology and pathophysiology. This non-canonical axis of the renin–angiotensin system consists of angiotensin 1–7, angiotensin 1–9, angiotensin-converting enzyme 2, the type 2 angiotensin II receptor (AT2R), the proto-oncogene Mas receptor and the Mas-related G protein-coupled receptor member D. Each of these components has been shown to counteract the effects of the classical renin–angiotensin system. This counter-regulatory renin–angiotensin system has a central role in the pathogenesis and development of various cardiovascular diseases and, therefore, represents a potential therapeutic target. In this Review, we provide the latest insights into the complexity and interplay of the components of the non-canonical renin–angiotensin system, and discuss the function and therapeutic potential of targeting this system to treat cardiovascular disease.
AB - The renin–angiotensin system is an important component of the cardiovascular system. Mounting evidence suggests that the metabolic products of angiotensin I and II — initially thought to be biologically inactive — have key roles in cardiovascular physiology and pathophysiology. This non-canonical axis of the renin–angiotensin system consists of angiotensin 1–7, angiotensin 1–9, angiotensin-converting enzyme 2, the type 2 angiotensin II receptor (AT2R), the proto-oncogene Mas receptor and the Mas-related G protein-coupled receptor member D. Each of these components has been shown to counteract the effects of the classical renin–angiotensin system. This counter-regulatory renin–angiotensin system has a central role in the pathogenesis and development of various cardiovascular diseases and, therefore, represents a potential therapeutic target. In this Review, we provide the latest insights into the complexity and interplay of the components of the non-canonical renin–angiotensin system, and discuss the function and therapeutic potential of targeting this system to treat cardiovascular disease.
UR - http://www.scopus.com/inward/record.url?scp=85071099405&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071099405&partnerID=8YFLogxK
U2 - 10.1038/s41569-019-0244-8
DO - 10.1038/s41569-019-0244-8
M3 - Review article
C2 - 31427727
AN - SCOPUS:85071099405
SN - 1759-5002
VL - 17
SP - 116
EP - 129
JO - Nature Reviews Cardiology
JF - Nature Reviews Cardiology
IS - 2
ER -